MedTrace Logo

24-hour Movement Behaviors Among Normal Weight, Overweight and Obese Adults

NCT05367570 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 250

Last updated 2024-04-12

No results posted yet for this study

Summary

The prevalence of adults with overweight (50%) and obesity (15%) reached high number in Belgium. Important lifestyle behaviors, i.e. sleep, sedentary time (SB), and physical activity (PA) subdivided into light physical activity (LPA) and moderate to vigorous physical activity (MVPA), have shown an impact on overweight and obesity characteristics (e.g. adiposity). However, these behaviors have often been investigated separately. Therefore, a recent shift in research emphasizes the importance of considering these behaviors as part of a 24-hour day.

Since these adults can benefit from an optimal 24-hour composition as part of a healthy lifestyle, it may be interesting to investigate the 24-hour movement composition among these adults. In addition, exploring different personal determinants, environmental determinants, and cardiometabolic markers will provide meaningful insights in developing an intervention.

Conditions

  • Overweight and Obesity

Interventions

BEHAVIORAL

Cross-sectional observational study

The first work package of this project is an explanatory cross-sectional study with no intervention.

Sponsors & Collaborators

  • University Ghent

    collaborator OTHER

  • University Hospital, Ghent

    lead OTHER

Principal Investigators

  • Bruno Lapauw, Professor · Ghent University Hospital - endocrinologist

  • Marieke De Craemer, Professor · University Ghent

Eligibility

Min Age
25 Years
Max Age
64 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-04-18
Primary Completion
2022-12-16
Completion
2023-10-31

Countries

  • Belgium

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05367570 on ClinicalTrials.gov